2 weeks ago

GS1 CEO urges next leap in QR code standardisation for medicines

GS1 CEO urges next leap in QR code standardisation for medicines
QR coding for medicines needs to take the next leap in standardization of codes: GS1 CEO · thehindubusinessline.com

Medicines in India are getting special codes called QR codes.

These codes are like tiny barcodes that you can scan with a phone.

They tell you important things about the medicine, like its name, who made it, and when it expires.

The government said many medicines must have these codes by certain dates.

Some medicines, like cancer drugs and vaccines, need them by 2027.

Other medicines, like antibiotics, need them by 2028.

A man named S Swaminathan works for a group called GS1 India that helps set standards for these codes.

He says the codes are good, but they need to be the same everywhere.

That way, everyone from the factory to the pharmacy can read them the same way.

This helps make sure medicines are real and safe.

He thinks there is still a long way to go to make this work perfectly.

Key facts

QR code mandate expansion
Covers cancer drugs, narcotics, psychotropic drugs, vaccines, and antimicrobials
Deadline for most drugs
July 1, 2027
Deadline for antimicrobials
July 1, 2028
Earlier initiative
Top 300 drug brands required QR/bar codes starting August 2023
Data elements per drug
Nine, including product ID, drug names, manufacturer details, batch number, and dates
Track-and-trace progress rating
2 out of 10, per GS1 India CEO
GS1 India origin
Set up by the Commerce Ministry and industry bodies; affiliate of GS1 Global

Quotes

Health Ministry

Indian government ministry overseeing medicine regulation

“The availability of these details through digital authentication tools will facilitate seamless verification and tracking of medicines across the supply chain.”
thehindubusinessline.com

S Swaminathan

Chief Executive Officer of GS1 India, supply‑chain standards organisation

“This strengthens patient safety, builds consumer confidence, and ensures that every stakeholder in the pharmaceutical supply chain benefits from transparency and interoperability.”
thehindubusinessline.com

Sources

Related news